Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

IM Cannabis Corp (IMCC) Stock Price & Analysis

188 Followers

IMCC Stock Chart & Stats

$0.64$0.05(7.59%)
At close: 4:00 PM EST
$1$2$3$4Aug 10Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2
Day’s Range
$0.59 - $0.64
52-Week Range
$0.58 - $62.40
Previous Close
$0.59
Volume
N/A
Average Volume (3M)
161.27K
Market Cap
$1.05M
Enterprise Value
$10.02M
Total Cash (Recent Filing)
$1.74M
Total Debt (Recent Filing)
$13.85M
Price to Earnings (P/E)
―
Beta
1.84
Next Earnings
Nov 16, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Regulated Cannabis Platform

Participation across regulated medical and adult-use markets gives IMCC an established operating framework and multiple product formats, including dried flower and other consumer cannabis products. Its licensed-channel model can support durable market access as regulated cannabis demand develops.

Strategic Simplification

Selling the European-focused subsidiary narrows IMCC's geographic scope and redirects resources toward its Israeli medical cannabis operations. The expected equity and working-capital benefits could improve financial flexibility while making the business easier to manage through its restructuring.

Additional Operating Capital

The new financing supplies near-term capital for corporate needs and the Israeli medical cannabis platform, helping maintain operations during restructuring. An existing institutional investor also participated, providing funding without an immediate requirement for full principal repayment.

Bears Say

Declining Revenue And Losses

Falling revenue alongside a widening net loss indicates weaker demand or execution and shows that the current cost structure is not scaling effectively. Unless the trend reverses, reduced operating scale can constrain reinvestment and prolong the path to sustainable profitability.

Weak Capitalization And Cash Burn

Negative equity and limited cash leave IMCC with reduced financial flexibility while liabilities remain substantial. Combined with recent operating losses, this capitalization increases dependence on external funding and can restrict the company's ability to invest in growth or absorb further deterioration.

Dilutive Financing Structure

The financing adds potential dilution through both conversion and warrants, while market-based conversion adjustments may increase the eventual share count. That can reduce existing shareholders' ownership and reflects a funding structure that may remain costly as the company rebuilds its balance sheet.

IM Cannabis Corp News

IMCC FAQ

What was IM Cannabis Corp’s price range in the past 12 months?
IM Cannabis Corp lowest stock price was $0.58 and its highest was $62.40 in the past 12 months.
What is IM Cannabis Corp’s market cap?
IM Cannabis Corp’s market cap is $1.05M.
When is IM Cannabis Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were IM Cannabis Corp’s earnings last quarter?
IM Cannabis Corp released its earnings results on Aug 13, 2026. The company reported -$10.198 earnings per share for the quarter.
Is IM Cannabis Corp overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does IM Cannabis Corp pay dividends?
IM Cannabis Corp does not currently pay dividends.
What is IM Cannabis Corp’s EPS estimate?
IM Cannabis Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IM Cannabis Corp have?
IM Cannabis Corp has 1,647,494 shares outstanding.
What happened to IM Cannabis Corp’s price movement after its last earnings report?
IM Cannabis Corp reported an EPS of -$10.198 in its last earnings report. Following the earnings report the stock price went down -6.053%.
Which hedge fund is a major shareholder of IM Cannabis Corp?
Currently, no hedge funds are holding shares in IMCC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology